Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Neurogastrx

Neurogastrx?uq=hBqTzBbB
2012 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$45M LATEST DEAL AMOUNT
3 INVESTORS
Description

Provider of biopharmaceutical research and development services designed to treat gastrointestinal disorders affecting the enteric nervous system. The company's biopharmaceutical research and development services addresses unmet needs of functional and motility gastrointestinal disorders, enabling patients to get relief from bowel disorders.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • 1608 West Campbell Avenue
  • Suite 210
  • Campbell, CA 95008
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Neurogastrx’s full profile, request a free trial.

Neurogastrx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 01-Aug-2018 $45M 000.00 000.00 Completed Generating Revenue
2. Seed Round 12-Sep-2016 00000 00.000 000 Completed Generating Revenue
1. Convertible Debt 01-Apr-2014 $2M $2M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Neurogastrx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Seed 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
To view this company’s complete Cap Table, request access »

Neurogastrx Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
5AM Ventures Venture Capital Minority 000 0000 000000 0
OrbiMed Venture Capital Minority 000 0000 000000 0
venBio Venture Capital Minority 000 0000 000000 0

Neurogastrx Executive Team (5)

Name Title Board
Seat
Contact
Info
Jim O'Mara President, Chief Executive Officer and Board Member
Cyril De Colle Ph.D Co-Founder, Board Member & Chief Scientific Officer
Jeffrey Johnston MD Chief Medical Officer

2 Former Executives

You’re viewing 3 of 5 executives. Get the full list »

Neurogastrx Board Members (6)

Name Representing Role Since Contact
Info
Aaron Royston MD venBio Board Member 000 0000
David Allison Ph.D 5AM Ventures Board Member 000 0000
Kevin Koch Ph.D OrbiMed Board Member 000 0000
Klaus Veitinger Ph.D OrbiMed Chairman 000 0000
Willie Quinn Self Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »